Bacterial colitis

Clinics in Colon and Rectal Surgery

Volumn 20, Issue 1, 2007, Pages 18-27

  Papaconstantinou, Harry T ^a   Thomas, J Scott ^a  

^a TEXAS A AND M UNIVERSITY SYSTEM   (United States)

Author keywords

Bacteria; Colitis; Diarrhea; Dysentery

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; ETHAMBUTOL; IMIPENEM; ISONIAZID; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE;

ABDOMINAL PAIN; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BLOODY DIARRHEA; CAMPYLOBACTER; CLINICAL FEATURE; COLITIS; DIAGNOSTIC APPROACH ROUTE; DIARRHEA; DISEASE ASSOCIATION; DYSENTERY; ESCHERICHIA; FECES ANALYSIS; FEVER; FOOD CONTAMINATION; HEMORRHAGIC COLITIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; PATHOPHYSIOLOGY; RISK FACTOR; SALMONELLA; SHIGELLA; SINGLE DRUG DOSE; TENESMUS; TUBERCULOSIS; TYPHOID FEVER; WATER CONTAMINATION; YERSINIA;

EID: 33847662847     PISSN: 15310043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-970196     Document Type: Article

References (67)

1. Ilnyckyj A. Clinical evaluation and management of acute infectious diarrhea in adults. Gastroenterol Clin North Am 2001;30:599-609
2. Ryan CA, Nickels M, Hargrett-Bean NT, et al. Massive outbreak of antimicrobial-resistant salmonellosis traced to pasteurized milk. JAMA 1987;258:3269-3274
3. MacKenzie WR, Schell WL, Blair KA, et al. Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis 1995;21:57-62
4. Ina K, Kusugami K, Ohta M. Bacterial hemorrhagic enter-ocolitis. J Gastroenterol 2003;38:111-120
5. Macdonald KL, O'Leary MJ, Cohen ML, et al. Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study. JAMA 1988;259:3567-3570
6. Peterson MC. Clinical aspects of Campylobacter jejuni infections in adults. West J Med 1994;161:148-152
7. Ebringer A, Wilson C. HLA molecules, bacteria and autoimmunity. J Med Microbiol 2000;49:305-311
8. Altekruse SF, Stern NJ, Fields PI, Swerdlow DL. Campylobacter jejuni-an emerging foodborne pathogen. Emerg Infect Dis 1999;5:28-35
9. Jacobs BC, van Doom PA, Schmitz PI, et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol 1996;40:181-187
10. Loss RW, Mangla JC, Pereira M. Campylobacter colitis presenting as inflammatory bowel disease with segmental colonic ulcerations. Gastroenterology 1980;79:138-140
11. Matsumoto T, Iida M, Kimura Y, Fujishima M. Culture of colonoscopically obtained biopsy specimens in acute infectious colitis. Gastrointest Endosc 1994;40:184-187
12. Oldfield EC, Wallace MR. The role of antibiotics in the treatment of infectious diarrhea. Gastroenterol Clin North Am 2001;30:817-836
13. Smith KE, Besser JM, Hedberg CW, et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med 1999;340:1525-1532
14. Levine MM. Antimicrobial therapy for infectious diarrhea. Rev Infect Dis 1986;8:S207-S216
15. Hoffner RJ, Slaven E, Perez J, Magana RN, Henderson SO. Emergency department presentations of typhoid fever. J Emerg Med 2000;19:317-321
16. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001;32:263-269
17. Chaudhuri A, Bekdash BA. Toxic megacolon due to Salmonella: a case report and review of the literature. Int J Colorectal Dis 2002;17:275-279
18. Musher DM, Rubenstein AD. Permanent carriers of non-typhosa salmonellae. Arch Intern Med 1973;132:869-872
19. Cariani G, Vandelli A. Salmonellosis-induced hemorrhage and ulcerations of the colon. Endoscopy 1993;25:488
20. Dagash M, Hayek T, Guallimidi Z, Yassin K, Brook JG. Transient radiological and colonoscopic features of inflammatory bowel disease in a patient with severe Salmonella gastroenteritis. Am J Gastroenterol 1997;92:349-351
21. Kamath R. Antibiotic therapy for Salmonella enteritis. J Paediatr Child Health 1999;35:372-374
22. Sanchez C, Garcia-Restoy E, Garau J, et al. Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial. J Infect Dis 1993;168:1304-1307
23. Rodriguez-Noriega E, Andrade-Villanueva J, Amaya-Tapia G. Quinolones in the treatment of Salmonella carriers. Rev Infect Dis 1989;11:S1179-S1187
24. Kotloff KL, Winickott JP, Ivanoff B, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 1999;77:651-666
25. DuPont HL, Hornick RB, Snyder MJ, Libonati JP, Formal SB, Gangarosa EJ. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis 1972;125:12-16
26. Mohle-Boetani JC, Stapleton M, Finger R, et al. Community wide shigellosis: control of an outbreak and risk factors in child day-care centers. Am J Public Health 1995;85:812-816
27. O'Sullivan B, Delpech V, Pontivivo G, et al. Shigellosis linked to sex venues, Australia. Emerg Infect Dis 2002;8:862-864
28. Sandvig K. Shigatoxins. Toxicon 2001;39:1629-1635
29. Bennish ML. Potentially lethal complications of shigellosis. Rev Infect Dis 1991;13:S319-S324
30. Tsuchiya N, Husby G, Williams RC, et al. Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid. J Clin Invest 1990;86:1193-1203
31. Speelman P, Kabir I, Islam M. Distribution and spread of colonic lesions in Shigellosis: a colonoscopic study. J Infect Dis 1984;150:899-903
32. Khuroo MS, Mahajan R, Zargar SA, et al. The colon in Shigellosis: serial colonoscopic appearances in Shigella dysenteriae. I. Endoscopy 1990;22:35-38
33. Lawson JM. Update on Escherichia coli O157:H7. Curr Gastroenterol Rep 2004;6:297-301
34. Tarr PI, Neill MA. Escherichia coli O157:H7. Gastroenterol Clin North Am 2001;30:735-751
35. Griffin P, Mead P, Sivapalasingam S. Escherichia coli O157:H7 and other enterohemorrhagic E. coli. In: Blaser M, Smith P, Greenberg H, et al, eds. Infections of the Gastrointestinal Tract. Philadelphia: Lippincott Williams & Wilkins; 2002:627-642
36. Huang D, Okhuysen P, Jiang Z, et al. Enteroaggregative Escherichia coli: an emerging enteric pathogen. Am J Gastroenterol 2004;99:383-389
37. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002;347:589-600
38. Crump JA, Sulka AC, Langer AJ, et al. An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm. N Engl J Med 2002;347:555-560
39. Shigeno T, Akamatsu T, Fujimori K, Nakatsuji Y, Nagata A. The clinical significance of colonoscopy in hemorrhagic colitis due to enterohemorrhagic Escherichia coli O157:H7 infection. Endoscopy 2002;34:311-314
40. Kelly J, Oryshak A, Wenetsek M, Grabiec J, Handy S. The colonic pathology of Escherichia coli O157:H7 infection. Am J Surg Pathol 1990;14:87-92
41. Miller FH, Ma JJ, Scholz FJ. Imaging features of enterohemorrhagic Escherichia coli colitis. AJR Am J Roentgenol 2001;177:619-623
42. Proulx F, Turgeon J, Delage G, et al. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J Pediatr 1992;121:299-303
43. Carter AO, Borczyk A, Carlson J, et al. A severe outbreak of Escherichia coli O157:H7 associated hemorrhagic colitis in a nursing home. N Engl J Med 1987;317:1496-1500
44. Ostroff SM, Kobayashi JM, Lewis JH. Infections of Escherichia coli O157:H7 in Washington State, the first year of statewide disease surveillance. JAMA 1989;262:355-359
45. Ryan CA, Tauxe R, Hosek G, et al. Escherichia coli O157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings. J Infect Dis 1986;154:631-638
46. Karch H, Strockbine NA, O'Brien AD. Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of shiga-like toxin producing strains by colony blot assay. FEMS Microbiol Lett 1986;35:141-145
47. Zhang X, McDaniel A, Wolf L, et al. Quinolone antibiotics induce shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 2000;181:664-670
48. Cimolai N, Carter J, Morrison B, et al. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolyticuremic syndrome. J Pediatr 1990;116:589-592
49. Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol 1998;37:667-672
50. Kato Y, Hattori Y, Ohya H, Yoshino S, Kato H. Acute terminal ileitis and Yersinia enterocolitica infection. Gastroenterol Jpn 1977;12:36-43
51. Matsumoto T, Iida M, Matsui T, et al. Endoscopic findings in Yersinia enterocolitica enterocolitis. Gastrointest Endosc 1990;36:583-587
52. Tuohy AM, O'Gorman M, Byington C, Reid B, Jackson WD. Yersinia enterocolitis mimicking disease in a toddler. Pediatrics 1999;104:36
53. Pham J, Bell S, Lanzarone J. Biotype and antibiotic sensitivity of 100 clinical isolates of Yersinia enterocolitica. J Antimicrob Chemother 1991;28:13-18
54. Preston MA, Brown S, Borczyk A, et al. Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated from Canada from 1972 to 1990. Antimicrob Agents Chemother 1994;38:2121-2124
55. Scavizzi MR, Alonso J, Philippon A, Jupeau-Vessieres AM, Guiyoule A. Failure of newer β-lactam antibiotics for murine Yersinia enterocolitica infection. Antimicrob Agents Chemother 1987;31:523-526
56. Han JK, Kim SH, Choi BI, Yeon KM, Han MC. Tuberculous colitis: findings at double-contrast barium enema examination. Dis Colon Rectum 1996;39:1204-1209
57. Horvath KD, Whelan RL, Weinstein S, Basner AL, Staugaitis SM, Greenebaum E. Isolated sigmoid tuberculosis. Report of a case. Dis Colon Rectum 1995;38:1327-1330
58. Breiter JR, Hajjar JJ. Segmental tuberculosis of the colon diagnosed by colonoscopy. Am J Gastroenterol 1981;76:369-373
59. Anand B. Abdominal tuberculosis. In: Weinstein WM, Hawkey CJ, Bosch J, eds. Clinical Gastroenterology and Hepatology. Philadelphia: Elsevier Mosby; 2005:331-336
60. Guth AA, Kim U. The reappearance of abdominal tuberculosis. Surg Gynecol Obstet 1991;172:432-436
61. Lisehora GB, Peters CC, Lee YT, Barcia PJ. Tuberculous peritonitis-do not miss it. Dis Colon Rectum 1996;39:394-399
62. Quinn TC, Goodell SE, Mkrtichian E, Schuffler MD, Wang SP, Stamm WE. Chlamydia trachomatis proctitis. N Engl J Med 1981;305:195-200
63. Tinmouth J, Rachlis A, Wesson T, Hsieh E. Lymphogranuloma venereum in North America: case reports and an update for gastroenterologists. Clin Gastroenterol Hepatol 2006;4:469-473
64. Rompalo AM. Diagnosis and treatment of sexually acquired proctitis and proctocolitis: an update. Clin Infect Dis 1999;28:S84-S90
65. Catterall RD. Sexually transmitted disease of the anus and rectum. Clin Gastroenterol 1975;4:659-669
66. Corman ML. Colon and rectal surgery. 5th ed. Philadelphia: Lippincott Williams Sc Wilkins; 2005:1648-1650
67. Schwebke JR, Whittington W, Rice RJ, Handsfield HH, Hale J, Holmes KK. Trends in susceptibility of Neisseria gonorrhoeae to ceftriaxone from 1985-1991. Antimicrob Agents Chemother 1995;39:917-920